This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Booz Allen Hamilton (BAH) Stock Moves -0.19%: What You Should Know
by Zacks Equity Research
Booz Allen Hamilton (BAH) concluded the recent trading session at $162.34, signifying a -0.19% move from its prior day's close.
Why Booz Allen Hamilton (BAH) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Omnicom to Report Q3 Earnings: Here's What You Should Know
by Zacks Equity Research
OMC's third-quarter 2024 earnings and revenues are likely to increase year over year.
Equifax Gears up to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
EFX's third-quarter 2024 revenues are expected to have gained from the company's strong performances across Europe and Latin America.
Booz Allen Hamilton (BAH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, Booz Allen Hamilton (BAH) stood at $161.26, denoting a +0.29% change from the preceding trading day.
Here's How Much a $1000 Investment in Booz Allen Hamilton Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Here's Why You Should Retain BAH Stock in Your Portfolio Now
by Zacks Equity Research
Booz Allen Hamilton stock is gaining from the VoLT strategy, a large addressable market and a strong liquidity position.
Booz Allen Hamilton (BAH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Booz Allen Hamilton (BAH) reachead $162.76 at the closing of the latest trading day, reflecting a +0.44% change compared to its last close.
Maximus Stock Ascends 11% in Six Months: Buy, Hold or Sell?
by Zacks Equity Research
MMS exhibits strong long-term growth potential, making it a stock worth monitoring for an ideal investment opportunity.
Booz Allen Hamilton (BAH) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
Booz Allen Hamilton (BAH) reachead $159.86 at the closing of the latest trading day, reflecting a +1.25% change compared to its last close.
Booz Allen Hamilton (BAH) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
Booz Allen Hamilton (BAH) concluded the recent trading session at $158.45, signifying a +0.93% move from its prior day's close.
Brokers Suggest Investing in Booz Allen (BAH): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Booz Allen (BAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Booz Allen Hamilton (BAH) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
Booz Allen Hamilton (BAH) concluded the recent trading session at $151.96, signifying a -0.1% move from its prior day's close.
VoLT Strategy Drives Booz Allen's Success Amid Rising Expenses
by Zacks Equity Research
BAH leverages its VoLT strategy to improve market position, scale businesses and grow its technology and solutions.
Booz Allen Hamilton (BAH) Stock Moves -1.46%: What You Should Know
by Zacks Equity Research
Booz Allen Hamilton (BAH) closed the most recent trading day at $156.46, moving -1.46% from the previous trading session.
Green Dot (GDOT) Stock Gains 20% Despite Q2 Earnings Miss
by Zacks Equity Research
Green Dot (GDOT) witnesses growth in the B2B and Money Movement Services segments in the second quarter of 2024.
Corpay (CPAY) Earnings & Revenues Surpass Estimates in Q2
by Zacks Equity Research
Corpay's (CPAY) top-line benefits from Corporate payments' revenues in the second quarter of 2024.
Should Maximus (MMS) Stock be in Your Portfolio Pre-Q3 Earnings?
by Shuvra Shankar Dey
Maximus' (MMS) third-quarter fiscal 2024 earnings and revenues are likely to increase year over year.
Booz Allen (BAH) Stock Gains 3% Despite Q1 Earnings Miss
by Zacks Equity Research
Booz Allen's (BAH) first-quarter fiscal 2025 earnings decline year over year while revenues increase.
Zacks.com featured highlights HCA Healthcare, CrediCorp, Booz Allen Hamilton and Hubbell
by Zacks Equity Research
HCA Healthcare, CrediCorp, Booz Allen Hamilton and Hubbell have been highlighted in this Screen of The Week article.
Scoop up These 4 GARP Stocks to Receive Handsome Returns
by Zacks Equity Research
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. HCA, BAP, BAH and HUBB are some stocks that hold promise.
Booz Allen Hamilton (BAH) Misses Q1 Earnings Estimates
by Zacks Equity Research
Booz Allen (BAH) delivered earnings and revenue surprises of -9.21% and 0.62%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
S&P Global (SPGI) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
S&P Global's (SPGI) second-quarter 2024 top line is likely to have gained from a rise in revenues across all segments.
Robert Half (RHI) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Robert Half's (RHI) second-quarter 2024 revenues and earnings are likely to have declined year over year.
How to Find Strong Business Services Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.